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Functionalisation and stabilisation of polymeric 
arsenical nanoparticles prepared by sequential 
reductive and radical cross-linking 
Joji Tanaka‡ʄ, Alexander Evans‡, Pratik Gurnani†, Andrew Kerr, Paul Wilson* 
University of Warwick, Department of Chemistry, Coventry, CV4 7AL, UK 
ABSTRACT 
The chemical reactivity of arsenic is diverse and distinctive depending upon its interchangeable oxidation 
states. Alkyl and aryl arsines (As(I)) exist as oligomers, composed of labile and redox responsive As-As 
bonds which have been exploited to form reactive and responsive materials. Here, the lability and 
reactivity of As(I)-functional polymeric nanoparticles, derived from thermoresponsive polymers 
P(PEGA20-b-[NIPAm80-n-co-AsAmn]) (P1, n = 4; P2, n = 11; P3, n = 15; P4, n = 18), is elaborated by 
in-situ reaction with functional acetylenes, resulting in the formation of vinylene-arsine cross-linked 
polymeric arsenical nanoparticles (NPV-As). Spherical particles with sizes < 35 nm have been prepared, 
which are adventitious for potential drug-delivery (e.g. tumour accumulation) applications. Functional 
acetylenes enable the introduction of reactive amine, acid and alcohol functional groups into the particles, 
while the use of propargyl-O-rhodamine ester results in the formation of fluorescent nanoparticles. The 
vinylene-arsine cross-linking confers increased stability of the polymeric arsenical nanoparticles in 
model biological redox conditions (GSH, H2O2, 5 mM) compared to those reported previously, with 
nanoparticle structures retained over 7 days. The parent polymeric arsenicals and the resulting 
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nanoparticles were all shown to exhibit limited cytotoxicity in vitro and cell uptake was confirmed by 
incubating fluorescent-labelled nanoparticles with PC3 cells. Furthermore, fluorescent confocal 
microscopy using the PC3 cell-line, confirmed that the nanoparticles were internalised by the cells with 
evidence of mitochondrial co-localisation, which supports a mitochondria-targeting of arsenic 
hypothesized based on work involving organoarsenical chemotherapeutics. Thus, this work demonstrates 
a novel strategy for the preparation of polymeric arsenical nanoparticles, with broad functional group 
tolerance, and expanded our emerging understanding of the in-vitro behaviour of this family of 
nanomaterials.   
INTRODUCTION 
The use of arsenic trioxide (Trisenox, As2O3) for effective treatment for acute promyelocytic leukaemia 
(APL) has revitalised the therapeutic potential of (in)organic arsenicals.1  Organic arsenicals 4-(N-(S-
glutathionylacetyl)amino) phenylarsonous acid (GSAO),2 4-(N-(S-penicillaminylacetyl)amino) 
phenylarsonous acid (PENAO)3 and S-dimethylarsino-glutathione (ZIO-101; Darinasparin)4 have gained 
much attention for use as mitochondrial targeting chemotherapeutic drugs, demonstrating higher potency 
and reduced cytotoxicity compared to inorganic counterparts. The activity of these trivalent organic 
arsenical (As(III)) drugs is attributed to their high affinity for proximal dithiols,5, 6 which are abundant 
in redox active proteins responsible for a number of crucial roles within the intracellular space, such as 
post-translational protein folding and redox homeostasis.7-9 For example, it has been postulated that 
GSAO and PENAO disrupt the mitochondrial membrane potential by cross-linking Cys57 and Cys257 of 
mitochondrial adenine nucleotide translocase (ANT), leading to opening of the mitochondrial 
permeability transition pore (MPTP).10  
 
The clinical renaissance of (in)organic arsenicals is beginning to manifest broader acceptance of the use 
of organic arsenicals in the field of polymer and (bio)materials science.11 Recently, Stenzel and co-
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workers have synthesised a PENAO-derived methacrylamide monomer and copolymerized it into the 
hydrophilic, corona-forming block of amphiphilic block copolymers to fabricate PENAO-functional 
polymeric nanoparticles.12 The presence of pendent thiol-philic As(III) groups was chemically confirmed 
by mono and dithiol substitution reactions and incorporation of PENAO into the corona of polymer 
nanoparticles was shown to improve the activity and cell uptake relative to PENAO alone. Moreover, in 
agreement with the proposed activity of PENAO, the As(III)-functional nanoparticles exhibited 
mitochondrial colocalisation alluding to the potential for active targeting with organelle specificity. 
Polymerisation-induced self-assembly (PISA) has also been employed to demonstrate the role and effect 
of the stabilizing (hydrophilic) PENAO-containing block on the reactivity and cytotoxicity of PENAO-
functional nanoparticles, whereby shorter, more-condensed stabilizing blocks exhibited up to 5-fold 
increase in toxicity.13  
 
The (bio)chemical reactivity and biological activity of arsenic is richly diverse and can be distinctive, 
depending upon its oxidation state, of which As(V), As(III) and As(I) can be considered to be biologically 
relevant. With this in mind we have adopted the long-term aim of developing polymeric arsenicals as a 
platform for functional (bio)materials wherein both the chemical reactivity and biological activity are 
accessible functions of the materials, typically in response to biological stimulus. Initially, α-As(V)-
functional (co)polymers were synthesized by aqueous single electron transfer living radical 
polymerisation (Aq-SET-LRP). The As(V) chain-end was readily reduced to As(III) in the presence of 
glutathione and the resulting polymers were shown to undergo highly efficient and reversible conjugation 
via re-bridging of reduced disulfides.14 The versatility, degree and controlled incorporation of As-
functionality present in polymeric arsenicals has been expanded using simple organic arsenical 
acrylamide monomers (AsAm) derived from commercially available p-arsanilic acid. Reversible 
addition fragmentation chain-transfer (RAFT) polymerisation has been employed to prepare polymeric 
arsenical scaffolds for post-polymerization modification of the pendent As(V) groups via sequential 
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reduction (to As(III)) and thiol substitution.15  
 
More recently, both Aq-SET-LRP and RAFT have been used to synthesise block copolymeric arsenicals 
capable of undergoing simultaneous thermally-induced self-assembly and reductive cross-linking. 
Considering the reactivity of the pendent As(V)-functional groups present in the block copolymers, two 
modes of cross-linking have been investigated. Reduction of the pendent As(V)-groups in the presence 
of hypophosphorus acid (H3PO2) and KI affords cross-linking via reductive coupling which proceeds 
with the formation of As-As bonds.16 The stability of the resulting particles in aqueous solution and 5 
mM GSH increases as a function of the AsAm mole ratio whilst under simulated oxidative stress (5 mM, 
H2O2) the particles disassembled irrespective of the AsAm mole ratio. These properties are mirrored by 
polymeric arsenical hydrogels prepared using the same chemistry.17 Alternatively, when reductive 
coupling is performed in the presence of polythiol reagents cross-linking proceeds through the formation 
more enthalpically favoured As-S bonds.18 These polymeric arsenical particles are markedly more stable 
in aqueous solution and 5 mM GSH; crucially the stability (i.e. responsivity) towards simulated oxidative 
stress, can be tuned as a function of the [As] : [SH] and thiol valency of the polythiol cross-linker.     
 
Arsines (As(I)) or cyclic oligoarsines (RAsn)
19, 20 are interesting functional groups for the development 
of responsive materials as the oligo-cyclic structures are readily accessible by reduction of the 
corresponding arsenic acids.21, 22 The resulting As-As bonds are labile, being prone to homolysis or 
hydrolysis and oxidation back to As(III) and As(V) respectively. Chujo and co-workers proposed that 
homolysis of the cyclic oligo-arsines resulted in the formation of arsenic biradicals and employed such 
structures as co-monomers for ring-collapsed radical alternating copolymerization (RCRAC) with 
acetylenes to form poly(vinylene arsines).23 Structurally, the poly(vinylene-arsines) were shown to have 
a backbone composed of alternating As(III) and vinylene groups in a trans-1,2 geometry with a 1 : 1 
stoichiometry, irrespective of the initial monomer feed. Crucially, the vinylene-arsine repeating unit was 
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shown to be resistant to oxidation by peroxides.  
 
Herein, we report the cross-linking of self-assembled polymeric arsenical nanoparticles via sequential 
reductive coupling and RCRAC in the presence of functional acetylenes. The resulting nanoparticles are 
oxidatively stable and use of propargyl-O-rhodamine-B ester during cross-linking provides access to 
fluorescent nanoparticles which have been used to confirm in vitro cell uptake.    
 
EXPERIMENTAL 
Materials & Instrumentation 
N-(4-(2,2,3,3,7,7,8,8-Octamethyl-1,4,6,9-tetraoxa-5λ5-arsaspiro[4.4]non-5-yl)-phenyl-2-propenamide) 
(AsAm(pin2))
15 and 2-((butylthio)-carbonothioyl) thio propanoic acid (PABTC) were synthesised 
according to the reported literature.24 N-Isopropylacrylamide (NIPAm, 97%) was purchased from sigma 
and recrystallized in hexane from diethyl ether. Dimethyl 2,2’-azobis(2-methylpropionate) (V601) was 
purchased from Wako. Potassium Iodide, glutathione (GSH), hydrogen peroxide (30 % w/w), 
hypophosphorous acid (50% w/w), and poly(ethylene glycol) methyl ether acrylate (PEGA, average Mn 
= 480 g mol-1) were purchased from Sigma Aldrich and used as received. Membrane dialysis tubing 
(nMWCO 3.5 kDa) was obtained from Spectrum Laboratories. Nuclear Magnetic Resonance (NMR) 
spectroscopy (1H NMR) was recorded on a Bruker HD  300 spectrometer (300 MHz) at 27 °C in either 
deuterated chloroform (CDCl3), dimethyl sulfoxide (δ6-DMSO) or water (D2O). Chemical shift values 
(δ) are reported in ppm. The residual proton signal of the solvent (δH = 7.26 ppm for CDCl3, δH = 2.50 
ppm for DMSO, δH = 4.76 ppm for D2O) was used as internal reference. ACDLABS software was used 
to analyse the data obtained. Size Exclusion Chromatography (SEC) was conducted using an Agilent 
390-LC MDS instrument equipped with differential refractive index (DRI), viscometry (VS), dual angle 
light scatter (LS) and dual wavelength UV detectors. The system was equipped with 2 x PLgel Mixed D 
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columns (300 x 7.5 mm) and a PLgel 5 µm guard column. The eluent was DMF containing 5 mmol 
NH4BF4 as an additive. Samples were run at 1 ml/min at 50 °C. Poly(methyl methacrylate) (PMMA) 
standards (Agilent EasyVials) were used for 3rd order calibration between 2 x 102 – 1.0 × 106 g mol-1. 
Analyte samples were filtered through 450 μm nylon filters pore size before injection. Mn,SEC and Đm 
values of the synthesized polymers were determined by conventional calibration using Agilent GPC/SEC 
software. Infrared (IR) spectra were recorded on a Bruker VECTOR-22 FTIR spectrometer using a 
Golden Gate diamond attenuated total reflection cell. Ultraviolet-visible (UV-Vis) calibration curves for 
experimental cross-linking density was recorded on an Agilent Technologies Cary 60 UV-Vis at a 
wavelength of 531 nm using a cuvette with a 1 cm path length and solutions of 1 mg/mL. The fluorescent 
intensity was monitored using Agilent Technologies Cary Eclipse Fluorescence Spectrophotometer at an 
excitation wavelength of 553 nm and collection of emission at 627 nm based on rhodamine B using a 
cuvette with a 1 cm path length and solutions of 1 mg/mL. Hydrodynamic diameters (Dh) and size 
distributions were determined by Dynamic Light Scattering (DLS) on a MALVERN Zetasizer Nano ZS 
operating at 25 °C with a 4 mW He-Ne 633 nm laser module. Measurements were made at a detection 
angle of 173° (back scattering). Measurements were repeated three times with automatic attenuation 
selection and measurement position. The results were analysed using Malvern DTS 6.20 software. PDI 
values were calculated using equation Eq 4.1 
𝑃𝐷𝐼 =  
𝜎2
𝑑2
 (Eq 1) 
Where σ is the standard deviation and d is the diameter both obtained from the number distribution. 
Atomic Force Microscopy (AFM) images were recorded on a Bruker Dimension Icon instrument 
operated in peak force tapping mode. The probes used were ScanAsyst silicon tips with a resonance 
frequency of 70 kHz and a spring constant of 0.4 N m-1. Samples were prepared by drop casting 5 μL of 
a 1 mg/mL aqueous nanoparticle solution onto a freshly cleaved sheet of mica, left to stand for 30 seconds 
and dried under of Nitrogen. Transition Electron Microscopy (TEM) samples were prepared by placing 
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a 400 mesh carbon coated Formvar copper grid onto a 20 µL droplet of aqueous nanoparticles (1 mg/mL) 
in a petri dish, leaving for 10 minutes prior to drawing off the solution. The grid was then stained by 
placing onto a 20 µl droplet of aqueous uranyl acetate (0.2 wt%), leaving for 10 minutes before drawing 
off excess liquid and allowed to air-dry overnight. TEM images were acquired using a JEOL 2100 TEM 
operating at a 200 kV accelerating voltage. Images were captured using Digital Micrograph® and 
analysed with ImageJ. 
 
General cell culture 
PC3 cells were purchased from ECACC and cultured as single monolayers at 310 K in a humidified 
atmosphere containing 5% CO2. Cells were sub-cultured at regular intervals and passages made by 
trypsinising cells when at 80-90% confluence. Media used was Dulbecco’s Modified Eagle Medium 
(DMEM) supplemented with 10% of foetal calf serum, 1% of L-glutamine and 1% 
penicillin/streptomycin. 
 
Cell viability  
PC3 cells were cultured in High Glucose DMEM medium supplemented with 10% fetal bovine serum. 
For cell viability evaluation, PC3 cells were seeded in a 96 well plate at a density of 1 × 104 cells per 
well. After 16 h, the culture medium was replaced by fresh media containing a series of dilution of the 
polymers (0.0625, 0.125, 0.25, 0.5, 1 and 2 mg/mL), prepared from stock solutions in PBS at 500 μM. 
Following 24 h incubation, the medium was removed and replaced with fresh medium. The cells were 
incubated with a freshly prepared solution of XTT (0.2 mg/mL) and N-methyl dibenzopyrazine methyl 
sulfate (250 μM) in medium for 16 h. Absorbance of the samples was finally measured using a plate 
reader at 450 nm and 650 nm. The data presented are representative of a minimum of two independent 





PC3 Cells were seeded into a black 96 imaging well plate with a clear bottom at a density of 5000 cells 
per well and allowed to grow for 24 h. The culture medium was replaced with media containing 
rhodamine labelled nanoparticles (100 µg/mL) 2 h and 24 h prior to imaging. Cellular fluorescence was 
measured using a Cytation 3 Cell Imaging Multi-Mode ReaderTM from Biotek®, with quantification 
from the Gen5TM software. Single cells were isolated using the blue channel (Hoechst 33258) using a 
secondary mask with an area of 12 µm. Following background reduction using a roll ball model (25 µm), 
fluorescence associated with rhodamine (RFP filter, λex = 531 nm, λem = 593 nm) was assigned as 
intracellular fluorescence. To compensate for the varying molar content of Rhodamine B during the NP 
cellular uptake studies, the internalisation values were normalised based on the relative fluorescence 
intensity of each particle. The normalisation factors were calculated from the gradients of the linear 
regions of concentration/ fluorescence intensity curves measured from 5 – 50 µg mL-1 at the wavelengths 
used to monitor cellular uptake (Fig. S17). Raw intracellular fluorescence was multiplied by the 
normalisation value for comparison. This correction has been added to the SI in Table S4. Data is 
represented as the arithmetic mean ± SD with experiments conducted in triplicates.  
 
Confocal microscopy 
7500 PC3 cells were seeded in a 10 well microscopy slide and left to incubate for 24 h, at 37°C in 5% 
CO2 atmosphere. The culture medium was replaced with media containing nanoparticles (100 µg/mL) 
and incubated for 24 h prior to imaging. Cells were stained with 1) Nuclear stain – Hoechst 33258 (0.5 
µg/mL; 30 min), 2) Lysotracker-Green (100 nM; 2 h), 3) Mitotracker green (100 nM; 30 min). 
Immediately prior to imaging, the cells were washed with PBS 3x and finally the media replaced with 
100 µL of phenol red free DMEM. Cells were imaged with a Zeiss 880 confocal microscope using a 40 
x objective, at 37°C with the following laser settings: 1) Hoechst dye (blue channel), 405 nm laser, 420-
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500 nm emission band. 2) Lysotracker and Mitotracker (green channels), 488 nm laser 500-550 nm 
emission band. 3) rhodamine labelled compounds and free rhodamine B (red channel), 561 nm laser 
(570-630 nm emission band). Images were processed with Fiji software.  
 
Synthetic methods 
Spectroscopic, chromatographic and microscopy data can be found in the SI. 
General procedure for synthesis of PEGA20-b-[NIPAM80-n-st-AsAmn] by RAFT, P1 – P4 
2-(((Butylthio)carbonothioyl)thio)propanoic acid (PABTC-C4, 24.8 mg, 0.1 mmol), PEGA480 (1 g, 2.1 
mmol) and 2,2’-azobis(2-methylpropionate) (V601, 1.44 mg, 6.3 µmol) were combined in a vial with 
2,2,2-trifluoroethanol (TFE, 1094 µl total volume) and deoxygenated by sparging with N2 for 15 min. 
Samples were taken before placing in an oil bath at 65 °C for 16 h and again upon completion for 1H 
NMR and SEC. Chain extension of the macro-RAFT agent was performed in-situ via addition of 
deoxygenated mixtures of N-isopropylacrylamide (NIPAM, 80-n eq), AsAm(pin2) (n eq), in varying feed 
ratios, and V601 (0.69 mg) in TFE (1,649 µl total volume). Samples were again taken before placing in 
an oil bath at 65 °C for 16 h and again upon completion for 1H NMR and SEC. The diblock copolymers 
were then dialysed (nMWCO 3.5 kDa) against dilute hydrochloric acid (HCl, 0.1 M) for 24 h, then 
deionised water for a further 24 h to ensure complete removal of the pinacol protecting group from 
AsAm(pin2) yielding the desired AsAm-functional block copolymers. The purified products were 
isolated by lyophilisation.  
 
Propargyl-O-rhodamine B ester25 
Rhodamine B (1 eq), DCC (1.5 eq), DMAP (0.2 eq) were dissolved in anhydrous DCM (50 ml) and 
stirred for 30 min. Propargyl alcohol (1.5 eq) was added and stirred at room temperature for 16 h. The 
crude product was purified by flash column in 1% methanol in DCM, the resulting product fractions 
combined and the solvent removed in vacuo to yield iridescent black crystals (57% yield). 1H NMR (400 
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MHz, CDCl3, 298 K) δ = 8.30 (d, JHH = 7.2 Hz, 1H, Hi), 7.84 (dd, JHH = 7.2, 7.3 Hz, 1H, Hg), 7.75 (dd, 
JHH = 7.9, 7.3 Hz, 1H, Hh), 7.31 (d, JHH = 7.9 Hz, 1H, Hf) 7.06 (d, JHH = 9.5 Hz, 2H, He), 6.90 (d, JHH = 
9.7 Hz, 2H, Hd) 6.80 (s, 2H, Hc) 4.60 (s, 2H, Hj) 3.63 (q, JHH = 13.3, 6.4 Hz, 8H, Hb) 2.40 (s, 1H, Hk) 
1.30 (t, JHH = 6.8, 12H, Ha); 
13C NMR (400 MHz, CDCl3 298 K) δ = 164.2, 75.6, 52.9, 46.2, 12.7,; LR-
MS (ESI, +ve) m/z (C31H34N2O3); expected 481.2, obtained 481.4 ([M+H]
+). 
 
General procedure for the self-assembly and cross-linking of PEGA20-b-[NIPAm80-n-st-AsAmn] via 
sequential reductive coupling and RCRAC 
As-functional polymers (P1 – P4) were dissolved in a deoxygenated solution of aqueous hypophosphorus 
acid (H3PO2, 10 wt%, 10 mg/mL polymer) and deoxygenated KI (1 vol% from a 3 wt% aq solution) was 
added. The solution was heated at 60 °C for 30 min. The functionalized acetylene (2.5 eq. w.r.t. [As]) 
and VA-044 (0.1 eq w.r.t [As]) were separately dissolved in HPLC grade H2O and sparged with N2 before 
addition to the hot polymer solutions, which were heated for a further 16 h. The resulting solutions were 
dialysed (nMWCO 3.5 KDa) against deionised water for 24 h and the crosslinked particles isolated by 
lyophilisation. The resulting solutions of functionalised nanoparticles were purified by aqueous dialysis 
(nMWCO 3.5 KDa) to removed unreacted acetylenes. The purified particles were isolated by 
lyophilisation. 
 
General procedure for particle stability 
Polymer nanoparticles were dissolved separately in deionised water, aqueous glutathione (5 mM) and 
aqueous H2O2 (5 mM) (1 mg/mL). The solutions were filtered through (450 μm nylon filters) into 
separate plastic cuvettes (with a lid) and incubated at 37 0C in a water bath. Disassembly was monitored 
through the measurement of changes in Dh as a function of time by DLS. 
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RESULTS AND DISCUSSION 
Synthesis of thermoresponsive PEGA20-b-[NIPAm80-n-st-AsAmn] scaffolds. Initially, 
thermoresponsive block copolymers composed of a corona-forming poly(ethylene glycol) methyl ether 
acrylate (PEGA, Mn = 480 gmol
-1) block and a core-forming N-isopropylacrylamide (NIPAm) block 
were synthesized using RAFT. In order to investigate vinylene-arsine cross-linking, AsAm was 
incorporated into the core-forming block at various mole ratios; targeting polymers with final 
compositions of P(PEGA20-b-[NIPAm80-n-co-AsAmn]) (P1, n = 5; P2, n = 10; P3, n = 15; P4, n = 20). 
Detailed discussion of the synthesis of the organic arsenic acrylamide monomer, (N-(4-(2,2,3,3,7,7,8,8-
octamethyl-1,4,6,9-tetraoxa-5λ5-arsaspiro[4.4]non-5-yl)-phenyl-2-propenamide; AsAm(pin)2) and 
subsequent polymerizations are reported in our previous work. 15, 18 This was repeated here with the 
initial PEGA480 block (targeting DPn = 20) synthesized using 2-((butylthio)-carbonothioyl) thio 
propanoic acid (PABTC) as the RAFT agent, V601 as initiator and trifluoroethanol (TFE) as the solvent 
at 65 °C ([PEGA480] = 1 M; [CTA]0 / [V601]0 = 50). The corona-forming PEGA480 blocks were obtained 
in high conversions (> 99%) with DPn = 23 – 27, according to 
1H NMR, close to the targeted DPn = 20.  
Size exclusion chromatography revealed well-defined peaks with good agreement between theoretical 
and experimental number average molecular weights (Mn,th = 11300 - 13200 gmol
-1
;
 Mn,SEC = 8400 -
10400 gmol-1) and low dispersities (Đm = 1.16 - 1.27) (Table 1, Fig. S2).  
Table 1. Arsenic functional block copolymers synthesized by RAFT. Monomer conversion determined 
by 1H NMR of protected polymer in CDCl3. SEC carried out using DMF as an eluent. 
 
 













P[PEGA23] > 99% 11300 9400 1.23    
P[PEGA23 -b-(NIPAm73-co-AsAm4)] > 99% 21800 17500 1.27 21200 13900 1.33 
 P[PEGA27] > 99% 13200 10400 1.27    
P2 P[PEGA27 -b-(NIPAm80-co-AsAm11)] > 99% 21800 22000 1.40 25400 10500 1.53 
 P[PEGA23] > 99% 11300 8400 1.23    
P3 P[PEGA23 -b-(NIPAm66- co-AsAm15)] > 99% 25500 21000 1.25 23100 9900 1.44 
 
P4 
P[PEGA24] > 99% 11800 8700 1.16    
P[PEGA24 -b-(NIPAm56- co-AsAm18)] > 99% 26300 21300 1.27 23300 10200 1.19 
 
Chain extension was achieved upon in-situ addition of varying amounts of AsAm(pin)2 and NIPAm 
(targeting overall DPn = 80) to the polymerization solution containing the PEGA480 macro-CTA. High 
conversions were again obtained (> 99%), and efficient re-initiation from the PEGA480 macro-CTA was 
confirmed by SEC through clear shift in the molecular weight (Mn,SEC = 17500 - 22000 gmol
-1) with 
retention of relative low dispersities (Đm = 1.25 - 1.40) (Table 1, Fig. S2). To obtain the desired, reactive, 
As(V) functional group, the AsAm(pin)2 pendent group was deprotected during acidic dialysis of the 
polymer scaffolds to yield pure As(V)-functional block copolymers P1 – P4 with increasing 
incorporation of AsAm (DPn,th = 5 – 20; DPn,NMR = 4 – 18).  
 
Self-assembly and cross-linking of PEGA20-b-[NIPAm80-n-st-AsAmn] via reductive coupling. To 
confirm that the As(V)-functional block copolymers were thermoresponsive and capable of undergoing 
self-assembly, as previously observed, variable temperature dynamic light scattering (DLS) in aqueous 
solution was performed (1 mg/mL). As expected, at 25 °C the block copolymers are fully soluble and 
small, unimeric, hydrodynamic diameters (Dh = 2.1 – 3.1 nm) were obtained. Upon heating to 60 °C, to 
promote the phase transition and insolubility of the NIPAm-containing block, Dh increased to 14 – 20 
nm, indicative of self-assembly into a higher order structure (Fig. S3). Likewise, to confirm that the 
AsAm groups were present and available for further reaction, P1 – P4 were heated in the presence of 
H3PO2 and KI to stimulate cross-linking through the formation of As-As bonds via reductive coupling. 
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The nanoparticles derived from P1 (NPAs(I)-4) were found to be unstable, undergoing disassembly during 
aqueous dialysis. However, the nanoparticles derived from P2 – P4 (NPAs(I)-11, NPAs(I)-15, NPAs(I)-18), with 
DPn,AsAm ≥ 10, retained their self-assembled structures during and post purification (Fig. S4). The 
morphology of the stabilized nanoparticles was characterized by using atomic force microscopy (AFM) 
and transition electron microscopy (TEM) of NPAs(I)-18 which confirmed the formation of nanoparticles 
with sizes < 25 nm (Fig. S5). This data is consistent with our previous work in which the stability of 
NPAs(I)-n was directly related to the mole fraction of the AsAm in the parent polymer i.e. P4 > P3 > P2 > 
P1.16 
 
Self-assembly and cross-linking of PEGA20-b-[NIPAm80-n-st-AsAmn] via sequential reductive 
coupling and RCRAC. In the work of Chujo et al,23, 26-32 the formation of poly(vinylene arsines) was 
proposed to proceeded via a RCRAC mechanism initiated by thermal decomposition of a radical initiator 
(2,2’-azobisisobutyronitrile, AIBN) to promote the homolysis of labile As-As bonds in organic solvents 
(benzene) resulting in the formation of As-biradicals. These reactive biradical intermediates can either 
recombine to reform labile As-As bonds, or they can add to acetylene (or vinyl)33, 34 monomers leading 
to the formation of a new As-C bond and a reactive vinyl radical during the rate determining step. The 
vinyl radical then rapidly reacts with As-As or other As-(bi)radicals resulting in the formation of another 




Scheme 1. Schematic representation of the self-assembly and cross-linking of polymer P1 – P4 through 
in-situ reductive coupling and RCRAC of As(I). The As(I) cross-linked nanoparticles are initially 
generated under elevated temperature in the presence of H3PO2 and KI to promote reductive coupling of 
the As(V) pendent groups before the addition of VA-044 and water soluble acetylenes to promote 
vinylene-arsine formation via RCRAC. 
 
Inspired by this, we hypothesized that performing sequential reductive coupling and RCRAC in-situ, by 
feeding in a mixture of a water soluble azo-initiator and water soluble acetylene to the NPAs(I)-n solutions 
at 60 °C would promote further reaction and cross-linking via the formation of vinylene-arsine bonds 
(NPV-As). 2,2'-Azobis[2-(2-imidazolin-2-yl)propane]dihydrochloride (VA-044) was identified as a 
suitable initiator and propargyl alcohol (PgOH), propargyl amine (PgNH) and propiolic acid (PAc) were 
selected as the acetylenes due to their water solubility and varying functionality (Scheme 1). Initially, 
polymers P1 – P4 were investigated using VA-044 and propargyl alcohol to promote further cross-
linking. A deoxygenated mixture of these reagents was added after 30 minutes of initial reductive 
coupling, to form NPAs(I)-n in-situ and then left for 16 h at 60 ºC. After extensive purification by aqueous 
dialysis, the nanoparticles were initially characterised by infra-red (IR) spectroscopy with changes in the 
region between 1000 – 750 cm-1, corresponding to the As-O bond signals, confirming the reduction of 
the pendant arsenic acid (As(V)) groups (Fig. 1). Furthermore, the broad signal (3700 - 2500 cm-1) 
present in the parent scaffold P4, attributed to the O-H groups of arsenic acid group decreased. 
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Incorporation of the propargyl alcohol was indicated by increase in the O-H signal at 3450 cm-1, whilst 
the absence of strong alkyne stretches at ~ 3300 cm-1 and 2100 cm-1 provide indirect evidence for 
incorporation via vinylene-arsine bond formation (vide infra).  
 
 
Fig. 1. Infrared spectra of P4 (black) and NPPgOH-18 (red) indicating reduction and modification of the 
pendent arsenic acid (As(V)) groups via changes in the O-H and As-O regions. 
Characterisation by DLS (1 mg/mL, H2O) revealed the presence of stable nanoparticles (NPPgOH-n; n = 
4, 11, 15, 18) at 25 °C (Dh = 10.7 – 16.8 nm) and 60 °C (Dh = 9.5 – 14.5 nm Table S1, Fig. 2A). The 
nanoparticles exhibited mild thermoresponsive character due to the presence of PNIPAm in the core-
forming block. Small contractions in the hydrodynamic volume upon heating apparent in the number 
distribution plots (Fig. 2A) were supported by reductions in size according to the intensity distribution 
and correlation coefficient plots (Fig. S6). The morphology of the nanoparticles was assessed via TEM 
and AFM using NPPgOH-18, revealing the formation of spherical nanoparticles with sizes < 35 nm (Fig. 




Fig. 2. (A) Particle size distribution curves of NPPgOH-n (n = 4, 11, 15, 18) by DLS (1 mg/mL, H2O) 
analysis at 25 °C and 60 °C; (B) AFM and (C) TEM of NPPgOH-18 (scale bar = 100 nm) 
 
The proposed stability of the NPPgOH-n particles is in contrast to the nanoparticles formed by reductive 
coupling alone; of which NPAs(I)-4 was not sufficiently stable, disassembling during purification (Fig. 
S4). We hypothesize that the increased stability is due to the formation vinylene-arsine bonds between 
polymer chains which elicits an increased inertia towards oxidation and results in the formation of As-C 
bonds, which are stronger than As-As bonds and further stabilized through nAs-πC conjugation.
35 The 
relative stability of NPPgOH-n was further investigated under model biological redox conditions i.e. in the 
presence of reduced glutathione ([GSH] = 5 mM) and hydrogen peroxide ([H2O2] = 5 mM) at 37 
oC. 
Redox and reactive oxygen species (ROS) responsive materials are promising candidates for 
nanomedicine based on the concentration gradient between healthy and diseased (e.g. tumours) tissues.36, 
37 For example, the extracellular concentration of GSH ranges between 2-20 μM whilst the intracellular 
concentration can reach 10 mM, which can increase 4-fold in tumour tissues.38 Likewise, the 
concentration of H2O2 is regulated at 20 nM in healthy cells, whilst in tumour cells, overproduction and 
retention can lead to concentrations up to 100 μM.39 Considering the redox reactivity of arsenicals, we 
have previously reported that in the presence of GSH or H2O2, nanoparticles cross-linked via As-S bonds 
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(NPAs-S) exhibited greater stability than those cross-linked via As-As bonds (NPAs(I)-n) and in both cases 
the stability can be related to the AsAm mole ratio present in the parent polymers.18 Here, all NPPgOH-n 
particles, including NPPgOH-4, were stable over the course of the experiment (7 days) in both GSH and 
H2O2 at intracellular and exaggerated intracellular concentrations respectively (Fig. 3). The enhanced 
stability of NPPgOH-n reflects the stability of the vinylene-arsine bonds proposed to constitute cross-
linking. In particular, the resilience to oxidation by H2O2 is in agreement with our hypothesis and the 




Fig. 3. Particle size distribution curves of NPPgOH-n (n = 4, 11, 15, 18) by DLS (1 mg/ml, H2O) as 
function of time in (A) aqueous GSH (5 mM) and (B) H2O2 (5 mM). 
 
To demonstrate the versatility of the RCRAC method, other functional water soluble alkynes were 
examined as co-monomers for cross-linking. Given the mechanism of RCRAC, it was hypothesized that 
there would be orthogonality with functional groups such as amines and carboxylic acids. Propargyl 
amine and propiolic acid were therefore employed as the acetylene monomers, yielding stabilised 
nanoparticles NPPgNH-n and NPPAc-n (n = 11, 15, 18) respectively from P2 – P4 (Dh = 12.7 – 30.9 nm, 
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Table S2, Fig. S7-S8).  Changes in the IR spectra in the region corresponding to the As-O bond signals 
(1000 – 750 cm-1) again indicated reduction and modification of the pendant arsenic acid (As(V)) groups 
(Fig. S9). Characterization of NPPgNH-18 and NPPAc-18 by TEM and AFM confirmed the formation of 
nanoparticles with similar size and morphology compared to NPPgOH-18 (Fig. S10-S11). The stability of 
NPPgNH-n and NPPAc-n in GSH and H2O2 was identical to NPPgOH-n with self-assembled structures retained 
over the course of the 7-day experiment (Fig. S12-S13). 
 
Cell viability of NPV-As. With potential biomedical applications in mind, and considering the chemical 
reactivity and biochemical activity of (in)organic arsenicals, it is critical to evaluate the cytotoxicity of 
all of the polymeric arsenicals and nanoparticles synthesized. Therefore, for purposes of screening and 
to be consistent with our previous work, the acute toxicity of the parent polymeric arsenicals (P1 - P4) 
and all subsequently formed nanoparticles (NPPgOH-n, NPPAc-n, and NPPgNH-n) was determined in vitro 
via a standard XTT assay using the Prostate carcinoma cell line (PC3) as a model. The polymers and 
corresponding nanoparticles were non-toxic up to the maximum concentration that was tested (2 mg/mL) 




Fig. 4. In vitro cell viability of (A) P1 - P4; (B) NPPgOH-n; (C) NPPgNH-n and (D) NPPAc-n using XTT 
viability assay with PC3 cell line. 
 
Preparation of fluorescent NPV-As using propargyl-O-rhodamine ester. The cell viability results are 
promising and in agreement with evaluation of related polymeric arsenical scaffolds and nanoparticles. 
However, it is not yet known whether the nanoparticles are taken up by the cells and if they are, how 
they are distributed through the cell in vitro. The sequential reductive coupling - RCRAC method offers 
the potential to introduce functionality suitable for cellular imaging into the nanoparticles. Rhodamine B 
was selected as a cheap water soluble fluorescent probe and an O-propargyl-ester derivative of rhodamine 
B was synthesized under standard Steglich esterification conditions using propargyl alcohol (Fig. S14).25 
The RCRAC method was then employed to prepare fluorescent nanoparticles (NPRh-n) using P1 - P4 and 
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propargyl-O-rhodamine B ester as the acetylene monomer. Initially, successful loading of the particles 
with the rhodamine alkyne was confirmed by IR and 1H NMR. Changes in the region corresponding to 
the As-O bond signals (1000 – 750 cm-1) indicated reduction and modification of the pendant arsenic 
acid (As(V)) groups (Fig. 5A), while the presence of multiple aromatic signals at 7.00 – 8.25 ppm can 
be attributed to incorporation of the O-propargyl-ester derivative of rhodamine B (Fig. 5B). 
Unfortunately, due to the to the expect vinyl proton arising from vinylene-arsine bond formation and 
other key polymer side-chain peaks in the NMR spectra being obscured it was not possible to quantify 
the extent of rhodamine incorporation by NMR in d6-DMSO. Further attempts to quantifiably detect the 
vinyl proton arising from vinylene-arsine bond formation in D2O and CDCl3 were also unsuccessful with 
the proposed vinyl signal at 6.86 and 6.54 ppm respectively obscured by overlap with the broad aromatic 




Fig. 5. (A) Infrared spectra of P4 (black) and NPRE-18 (purple) indicating reduction and modification of 
the pendent arsenic acid (As(V)) groups via changes in the As-O region. (B) 1H NMR and zoomed inset 
(d6-DMSO, 400 MHz, 50 mg/mL) showing incorporation of the rhodamine B O-propargyl-ester in NPRE-
18. 
Pleasingly, the NPRh-n obtained were found to be stable at 25 °C with comparable sizes (Dh = 16.3– 26.7 
nm) and morphologies to NPPgOH-n, NPPAc-n, and NPPgNH-n according to characterization by DLS (Fig. 
6A, Fig. S16, Table S3), AFM (Fig. 6C) and TEM (Fig. 6D) respectively. Likewise, the stability of 
NPRh-n in GSH and H2O2 was identical to NPPgOH-n with self-assembled structures retained over 7 days 
(Fig. S17). Most significantly, the nanoparticles were also shown to be fluorescent using fluorescence 
spectroscopy (λex = 553 nm; λem = 617 nm), confirming successful loading with the rhodamine (Fig. 6B). 
Fluorescence measurements of rhodamine-B (acid) revealed excitation and emission wavelengths of λex 
= 554 nm and λem = 584 nm, whilst propargyl-O-rhodamine B ester gave excitation and emission 
wavelengths of λex = 565 nm and λem = 595 nm. In order to verify that the propargyl-O-rhodamine B 
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ester had been incorporated into the nanoparticles, and to investigate whether any hydrolysis of the ester 
occurred under the acidic conditions imposed during cross-linking, an 1H NMR experiment in which the 
propargyl-O-rhodamine B ester was subjected to the cross-linking reaction conditions (H3PO2, KI, 60 °C, 
overnight) was performed. Comparison of the spectra at t = 0 and after heating overnight revealed 
identical structures suggesting that no detectable hydrolysis occurred during the course of the cross-
linking (Fig. S18).  
Based on the proposed 1 : 1 stoichiometry of acetylene and arsenic in poly(vinylene-arsines) and using 
ultraviolet-visible (UV-Vis) spectroscopy, by extrapolating the concentration from a calibration graph of 
propargyl-O-rhodamine B ester (Fig. S19), the degree of cross-linking in NPRh-n was semi-quantitatively 
determined to be between 7 – 32 %. This corresponds to between 1 and 2 AsAm groups per polymer 
chain reacting to the form the vinylene-arsine cross-links, which is low considering the observed 
enhancement in stability relative to NPAs(I). The low level of cross-linking can be attributed to the 
structure of the acetylenes employed for the RCRAC reaction. During the investigations of the synthesis 
of linear poly(vinylene-arsines) it was recognized that aromatic acetylenes (e.g. phenylacetylene) were 
better monomers for RCRAC than aliphatic acetylenes, with the increased relative stability of the vinyl 
radical adjacent to the aromatic ring proposed to the promote the polymerisation.28 The acetylenes 
employed in this work will form relatively less stable vinyl radicals (than aromatic acetylenes). 





Fig. 6. Schematic representation of the cross-linking of P1 – P4 using propargyl-O-rhodamine B ester to 
generate fluorescent nanoparticles nanoparticles, NPRh-n (n = 4, 11, 15, 18). (A) Particle size distribution 
curves by DLS (1 mg/mL); (B) fluorescence spectrum of NPRh-18 (λEx = 553 nm, λEm = 627 nm); (C) 
AFM and (D) TEM of NPRh-18 (scale bar = 100 nm). 
 
The propargyl-O-rhodamine B ester functionalised nanoparticles were investigated as models for loading 
and release of active compounds into the polymeric arsenical nanoparticles. Thus, comparative rates of 
hydrolysis from rhodamine-loaded particles NPRE-18 (1 mg/mL in phosphate buffer solution (PBS)) were 
determined via dialysis experiments performed at pH = 10.0 (0.01 M sodium hydroxide); 7.0 (PBS); and 
5.0 (0.01 M acetic acid); monitoring release by fluorescence measurements on aliquots of the dialysis 
media (Fig. 7). Under neutral (pH = 7.0) and mildly acidic (pH = 5.0) conditions very little release was 
observed over course of the experiment (7 days). However, under basic conditions (pH = 10.0), after a 
lag period of ~ 30 hours, significant hydrolysis was observed. Although, hydrolysis was not observed in 
a more physiologically relevant pH range, hydrolysis of the propargyl-O-rhodamine B ester bond 
indirectly confirms loading of rhodamine and alludes to the potential to load and release active 
compounds into the polymeric arsenical nanoparticles using the RCRAC approach, which has not 
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previously been demonstrated. 
 
 
Fig. 7. Fluorescence intensity measurements taken during dialysis of NPRE-18 (1 mg/mL) in a variety of 
aqueous solutions to correlating to the rate of hydrolysis of rhodamine-O-propargyl-ester bond with 
solution pH.  
 
Cell uptake and co-localization of NPRh-n. PC3 cells were selected as the model cell line for uptake 
considering their use in viability assays during this and previous work. This would help determine 
whether the low toxicity of the particles was related to the particle composition/structure or an artefact 
of a lack of internalisation. Prior to cellular uptake studies, fluorescence normalisation correction curves 
were plotted for each NPRh-n in order to normalise the intracellular fluorescence with the intrinsic particle 
fluorescence to quantify the relative uptake (Fig. S20, Table S4). Subsequently, an increased intracellular 
fluorescence indicated that cell uptake had occurred after 2 hours of incubation with the NPRh-n (Fig. 
S21) and uptake did not increase with longer incubation times e.g. 24 hours (Fig. S22). This suggests 
that the reported cell viability is a result of intrinsic low toxicity of the nanoparticles against PC3 cells, 
as opposed to evasion from cellular uptake. Increased cellular uptake was observed with increasing mole 
ratios of AsAm in the parent polymers (P1 – P4) with NPRh-18 and NPRh-15 showing higher uptake than 
NPRh-11 and NP Rh-4 (Fig. 8). The size, shape and stability of nanoparticles is known to have an impact 
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on cellular uptake.40-44 However, the nanoparticles fabricated during this work all have similar size and 
shape, with spherical nanoparticles of sizes < 35 nm being isolated, which are the ideal shape and size 
for in vivo tumour accumulation.45-47 The only notable difference between the particles formed is the 
mole ratio of AsAm, which increases in the parent polymers from P1 – P4. This alludes to potential 
targeting or stimulation of uptake (e.g. thiol-mediated)48, 49 conferred by the presence of the arsenic in 
the nanoparticle composition; work is ongoing to investigate this.  
 
 
Fig. 8. Relative fluorescence intensity of NPRh-n (n = 4, 11, 15 and 18) in PC3 cells with a nanoparticle 
concentration of 100 µg mL-1 after 2 and 24 hours of incubation. Following background reduction using 
a roll ball model (25 µm), fluorescence associated with rhodamine (RFP filter, λex = 531 nm, λem = 593 
nm) was assigned as intracellular fluorescence. Data is represented as the arithmetic mean ± SD with 
experiments conducted in triplicate. 
 
To further investigate cell uptake of NPRh-n, fluorescent confocal microscopy was used to track 
intracellular co-localisation. It was hypothesised that, due to their size, the nanoparticles would enter the 
cells through an energy dependent mechanism involving trafficking through a probable endosomal 
pathway.50 It was therefore reasonable to assume possible trafficking of the nanoparticles to the 
lysosomes upon cellular entry. Thus, the PC3 cells were initially stained with lysosomal stain, lysotracker 
green, and incubated with NPRh-18 (100 µg mL-1). After 24 hours NPRh-18 appears to be punctuated across 
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able to escape along the endosomal pathway before reaching the lysosome or they enter the cell via an 
alternative mechanism.51  
 
 
Fig. 9. Confocal fluorescent microscopy images of PC3 cells with NPRh-18. (A) Hoechst 33258; (B) 
Rhodamine-B; (C) Lysotracker green; (D) Overlay of channels indicating lack of lysosomal co-
localisation of the nanoparticles (scale bar = 30 µm) 
 
Considering the biochemical affinity and activity of (in)organic arsenicals towards the mitochondria, 
mitochondrial co-localization of NPRh-18 was then investigated. The mitochondria of PC3 cells were 
stained with mitotracker-green and incubated with NPRh-18. Although the nanoparticles are distributed 
throughout the cell, there is juxtaposition of the mitochondrial and rhodamine stains indicative of co-
localisation (Fig. 10). This can be attributed to targeting effects and the reactivity/affinity of unreacted 




Fig. 10. Confocal fluorescent microscopy images of PC3 cells with NPRh-18. (A) Hoechst 33258; (B) 
Rhodamine-B; (C) Mitotracker green; (D) Overlay of channels indicating lack of lysosomal co-
localisation of the nanoparticles (scale bar = 30 µm) 
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Finally, to rule out that co-localisation of NPRh-18 was as an artefact of diffusion of rhodamine leaching 
from the particles during the assay, co-localization assays were repeated using only free rhodamine. 
Although there appears to be some co-localization in the lysosome (Fig. S23), there is no evidence of co-
localization in the mitochondria (Fig. S24) with rhodamine B appearing to be diffusely distributed 
throughout the cell. 
 
The clinical success of arsenic trioxide (treatment of acute promyelocytic leukaemia) and organic 
arsenicals (for the treatment of much broader spectrum malignancies), relies on the synergy between 
chemical reactivity and biological activity of the arsenic functionality present. The apparent 
mitochondrial targeting properties of the polymeric arsenical nanoparticles reported here, along with the 
ability to tune stability, responsivity and functionality through the pendent AsAm groups (e.g. NPAs(I), 
NPAs-S and NPV-As) are attractive properties. In the long-term, the diverse chemistry of organic arsenicals 
and the potential for synergy between chemical and biological activity, could make polymeric arsenical 
nanomaterials viable candidates for drug-delivery and other chemotherapeutic applications. 
 
CONCLUSION 
Sequential reductive coupling and RCRAC, in the presence of functional acetylenes, has been introduced 
as a novel method to simultaneously assemble and cross-link thermoresponsive polymeric arsenical 
scaffolds (P(PEGA20-b-[NIPAm80-n-co-AsAmn]); P1, n = 4; P2, n = 11; P3, n = 15; P4, n = 18). The 
resulting nanoparticles (NPV-As) are spherical with sizes < 35 nm and exhibit markedly enhanced stability 
under model biological redox conditions (GSH, H2O2, 5 mM) compared to related nanoparticles (NPV-As 
> NPAs-S > NPAs(I)). Propargyl alcohol, amine and propiolic acid were employed as functional acetylenes, 
demonstrating orthogonality of the RCRAC method with useful functional groups. Furthermore, use of 
propargyl-O-rhodamine B ester furnished fluorescent nanoparticles that were subsequently used to 
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investigate in vitro properties of NPV-As. Polymers P1 – P4 and nanoparticles NPV-As (NPPgOH-n, NPPgNH-
n, NPPAc-n, NPRh-n) all exhibited limited cytotoxicity in vitro against PC3 cells. Incubation of the 
fluorescent particles NPRh-n with PC3 cells, revealed cell uptake within 2 hours at 37 °C, while confocal 
microscopy using NPRh-18 revealed co-localization in the mitochondria. This suggests that the NPRh-18 
either enter the cell via an expected endosomal pathway and then evade trafficking to the lysosome or 
alternatively, that they are internalized via a different uptake mechanism. Furthermore, the apparent 
affinity of NPRh-18 for the mitochondria supports a working hypothesis, based on clinically relevant 
organic arsenicals and recently reported polymeric arsenical nanoparticles that exhibit high affinity and 
activity for the mitochondria, that polymeric arsenicals nanomaterials (NPV-As, NPAs-S, NPAs(I)) could be 
viable candidates for drug delivery and other biomedical applications. 
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Functional and stable polymeric arsenical nanoparticles can be prepared by sequential reductive coupling 
and ring-collapse radical alternating copolymerisation (RCRAC). 
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